EE9800082A - Transdermaalne maatrikssüsteem, selle valmistamismeetod ja kasutamine - Google Patents

Transdermaalne maatrikssüsteem, selle valmistamismeetod ja kasutamine

Info

Publication number
EE9800082A
EE9800082A EE9800082A EE9800082A EE9800082A EE 9800082 A EE9800082 A EE 9800082A EE 9800082 A EE9800082 A EE 9800082A EE 9800082 A EE9800082 A EE 9800082A EE 9800082 A EE9800082 A EE 9800082A
Authority
EE
Estonia
Prior art keywords
weight
parts
pct
matrix system
group
Prior art date
Application number
EE9800082A
Other languages
English (en)
Inventor
Math Marie-Christine
Teillaud Eric
Bevan Bruno
Original Assignee
Laboratoires D'hygiene Et De Dietetique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires D'hygiene Et De Dietetique filed Critical Laboratoires D'hygiene Et De Dietetique
Publication of EE9800082A publication Critical patent/EE9800082A/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Telephonic Communication Services (AREA)
  • Soy Sauces And Products Related Thereto (AREA)
  • Steroid Compounds (AREA)
EE9800082A 1995-09-27 1996-09-25 Transdermaalne maatrikssüsteem, selle valmistamismeetod ja kasutamine EE9800082A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9511326A FR2739032B1 (fr) 1995-09-27 1995-09-27 Systeme matriciel transdermique d'administration d'un oestrogene et/ou d'un progestatif a base d'eva, procede de preparation et utilisation en therapeutique
PCT/FR1996/001494 WO1997011687A1 (fr) 1995-09-27 1996-09-25 Systeme matriciel transdermique

Publications (1)

Publication Number Publication Date
EE9800082A true EE9800082A (et) 1998-10-15

Family

ID=9482961

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9800082A EE9800082A (et) 1995-09-27 1996-09-25 Transdermaalne maatrikssüsteem, selle valmistamismeetod ja kasutamine

Country Status (25)

Country Link
US (1) US6013276A (et)
EP (1) EP0852492B1 (et)
JP (1) JPH11514988A (et)
KR (1) KR19990063732A (et)
CN (1) CN1083259C (et)
AT (1) ATE209031T1 (et)
AU (1) AU702542B2 (et)
BG (1) BG102322A (et)
BR (1) BR9610665A (et)
CA (1) CA2233162A1 (et)
CZ (1) CZ95398A3 (et)
DE (1) DE69617252T2 (et)
DK (1) DK0852492T3 (et)
EE (1) EE9800082A (et)
ES (1) ES2170266T3 (et)
FR (1) FR2739032B1 (et)
HU (1) HUP9900375A3 (et)
IL (1) IL123594A0 (et)
NO (1) NO981252D0 (et)
NZ (1) NZ319181A (et)
PL (1) PL325644A1 (et)
PT (1) PT852492E (et)
SK (1) SK282613B6 (et)
TR (1) TR199800563T1 (et)
WO (1) WO1997011687A1 (et)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10211832A1 (de) * 2002-03-16 2003-10-02 Lohmann Therapie Syst Lts Hormonhaltiges transdermales therapeutisches System mit einem Wirkstoffreservoir auf der Basis von Vinylacetat-Vinylpyrrolidon-Copolymer mit verbesserter Kohäsion
AU2004233997C1 (en) * 2003-04-29 2014-01-30 Massachusetts Institiute Of Technology Methods and devices for the sustained release of multiple drugs
CA2856520C (en) 2011-11-23 2021-04-06 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
AU2015264003A1 (en) 2014-05-22 2016-11-17 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
CA3020153A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3049628C2 (de) * 1980-12-31 1982-10-21 Basf Ag, 6700 Ludwigshafen Verfahren zur Überwachung des Entstehens und Fortschreitens von Rissen in Maschinenteilen und Bauteilen sowie eine Vorrichtung zur Durchführung des Verfahrens
JPS58189115A (ja) * 1982-04-30 1983-11-04 Kowa Co 外用剤
US4816258A (en) * 1987-02-26 1989-03-28 Alza Corporation Transdermal contraceptive formulations
FR2612785A1 (fr) * 1987-03-25 1988-09-30 Lhd Lab Hygiene Dietetique Dispositif auto-adhesif d'administration d'un principe actif par voie percutanee
JPH03275619A (ja) * 1990-03-23 1991-12-06 Nitsusui Seiyaku Kk 外用剤組成物
US5286490A (en) * 1990-05-04 1994-02-15 Colgate-Palmolive Company Transdermal fluoride medication
US5122382A (en) * 1990-10-29 1992-06-16 Alza Corporation Transdermal contraceptive formulations, methods and devices
US5453279A (en) * 1992-04-21 1995-09-26 Tbs Laboratories, Inc. Enhancing transdermal absorption compositions; transdermal dosage form; and process
FR2717688B1 (fr) * 1994-03-28 1996-07-05 Lhd Lab Hygiene Dietetique Système matriciel transdermique d'administration d'un oestrogène et/ou un progestatif à base d'EVA.

Also Published As

Publication number Publication date
AU702542B2 (en) 1999-02-25
DE69617252T2 (de) 2002-07-25
CA2233162A1 (en) 1997-04-03
MX9802327A (es) 1998-08-30
PL325644A1 (en) 1998-08-03
AU7134996A (en) 1997-04-17
NO981252L (no) 1998-03-19
ES2170266T3 (es) 2002-08-01
CN1083259C (zh) 2002-04-24
IL123594A0 (en) 1998-10-30
NZ319181A (en) 1998-10-28
DE69617252D1 (de) 2002-01-03
EP0852492B1 (fr) 2001-11-21
WO1997011687A1 (fr) 1997-04-03
BR9610665A (pt) 1999-07-13
FR2739032A1 (fr) 1997-03-28
BG102322A (en) 1998-10-30
SK40698A3 (en) 1998-09-09
CN1197390A (zh) 1998-10-28
KR19990063732A (ko) 1999-07-26
ATE209031T1 (de) 2001-12-15
JPH11514988A (ja) 1999-12-21
NO981252D0 (no) 1998-03-19
HUP9900375A2 (hu) 1999-06-28
SK282613B6 (sk) 2002-10-08
HUP9900375A3 (en) 1999-11-29
PT852492E (pt) 2002-05-31
CZ95398A3 (cs) 1998-07-15
US6013276A (en) 2000-01-11
FR2739032B1 (fr) 1997-11-21
DK0852492T3 (da) 2002-05-13
TR199800563T1 (xx) 1998-06-22
EP0852492A1 (fr) 1998-07-15

Similar Documents

Publication Publication Date Title
EE9800082A (et) Transdermaalne maatrikssüsteem, selle valmistamismeetod ja kasutamine
NO981315L (no) Transdermalt matrikssystem
DE58909793D1 (de) Neue Benzopyran-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung sowie die Verbindungen enthaltenden Zubereitungen
MX9602563A (es) Compuestos carbociclicos.
AU648319B2 (en) Process for the stereoselective preparation of phenylisoserin derivatives
IE830233L (en) Imidazoles
ZA913827B (en) Process for the enantioselective preparation of phenylisoserine derivatives
NO982987L (no) Amidinoproteasehemmere
DK164326C (da) 6,6-ethylen-15,16-methylen-3-oxo-17alfa-pregn-4-en-21,17-carbolactoner, fremgangsmaade til deres fremstilling og farmaceutiske praeparater indeholdende dem
ES8404850A1 (es) Procedimiento para la obtencion de 2-nitro-1,1-etendiaminas
CA2106642A1 (en) Carbazolone derivatives and process for preparing the same
AU5644296A (en) Novel heterocyclic chemistry
AU6826887A (en) 5-substituted octahydroindolizine analgesics compounds and 7-keto intermediates
EP0187162A4 (en) NOVEL RADIOACTIVE IODOSPIROPERIDOL AND ITS PREPARATION METHOD.
GR3000773T3 (en) 2,2;6,6-diethylene-3-oxo-17-alpha-pregn-4-ene-21,17-carbolactones, process for their preparation and pharmaceutical compositions containing them
RU98107820A (ru) Трансдермальная матричная система
NO945093L (no) Målrettet avgivelse av vekstfaktorer for benregenerering
TH9839EX (th) อนุพันธ์โดโลเบนโซควิโนลีน,การเตรียมสารเหล่านั้นและการใช้สารเหล่าเป็นยาต่อต้านอาการหัวใจเต้นไม่ปกติ
UA20112A (uk) Спосіб підвищеhhя скоротливої активhості ішемізоваhого міокарду у хворих hа ішемічhу хворобу серця
TH9839A (th) อนุพันธ์โดโลเบนโซควิโนลีน,การเตรียมสารเหล่านั้นและการใช้สารเหล่าเป็นยาต่อต้านอาการหัวใจเต้นไม่ปกติ
EP0346133A3 (en) Process for the preparation of macrolide compounds
PT828848E (pt) Preparacao de compostos hidroxi por bioconversao com dioxigenase
JPS5414998A (en) Prostaglandin i2 analog and its preparation
TH14339EX (th) กรรมวิธีใหม่สำหรับผลิตอนุพันธ์ 13-อีเธอร์ของมิลบีไมซิน, และอินเทอร์มิเดียทชนิดใหม่ของสารดังกล่าว